investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

RECRO PHARMA INC
(75629F109)

Funds Reporting Holdings of RECRO PHARMA INC according to 13F filings
Firm Name Shares Held / Principal Amount Market Value Option Report Period Effectiveness Date
Broadfin Capital LLC 1,561,617 $15,882k Jun 30, 2019 Aug 14, 2019
Corsair Capital Management LP 742,900 $7,555k Jun 30, 2019 Aug 13, 2019
North RUN Capital LP 315,338 $3,207k Jun 30, 2019 Aug 14, 2019
Acadian Asset Management LLC 258,740 $2,631k Jun 30, 2019 Aug 8, 2019
Brandywine Global Investment Management LLC 140,000 $1,424k Jun 30, 2019 Aug 14, 2019
Fondren Management LP 95,000 $966k Jun 30, 2019 Aug 14, 2019
Monarch Partners Asset Management LLC 77,687 $790k Jun 30, 2019 Aug 8, 2019
Spark Investment Management LLC 70,700 $719k Jun 30, 2019 Aug 12, 2019
Dupont Capital Management Corp 55,394 $563k Jun 30, 2019 Jul 30, 2019
Campbell & Company Investment Adviser LLC 38,989 $397k Jun 30, 2019 Jul 10, 2019
Prelude Capital Management LLC 337 $3k Jun 30, 2019 Aug 14, 2019

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.